Navigation Links
Huntsville Hospital Signs With Health Care Systems, Inc. for Automated Medication Reconciliation Services
Date:7/21/2008

MONTGOMERY, Ala. and HUNTSVILLE, Ala., July 21 /PRNewswire/ -- Health Care Systems, Inc. (HCS), a leading provider of medication safety solutions and the market leader in medication reconciliation solutions, has entered into an agreement with Huntsville Hospital System, one of the largest locally owned not-for-profit hospitals in the nation with 881 licensed acute care beds. Huntsville Hospital serves as a teaching facility for The University of Alabama at Birmingham's Family Medicine Residency Program in Huntsville. In addition, the hospital serves as a primary site for more than 50 national drug research projects. Huntsville Hospital System has used HCS Medication Reconciliation house-wide since March 2008.

HCS Medication Reconciliation, Health Care Systems' automated medication history service, enables reducing preventable adverse medication events, promoting operational efficiencies, and improving compliance with The Joint Commission National Patient Safety Goal 8a. HCS Medication Reconciliation provides hospitals with the ability to retrieve community pharmacy prescription fill and refill information at the time of patient admission.

"HCS looks forward to working with Huntsville Hospital in the use of HCS Medication Reconciliation in their hospitals. HCS Medication Reconciliation will help Huntsville meet their goals of clinician time savings and improved patient safety," said Dwight Henderson, CEO, Health Care Systems. Utilizing historical prescription information, HCS Medication Reconciliation automatically pushes a patient's medication history to the clinician at time and point of admission in the form of a printed or electronic report. This data is further enhanced by providing alerts related to duplicate therapy, potential interactions, and compliance. HCS Medication Reconciliation adds an additional layer of accuracy and confidence for the caregiver assigned to collecting this information. Utilizing HCS' Interface engine, which has successfully interfaced with many Hospital Information Systems and Automated Dispensing Devices, makes the implementation quick, easy, and vendor neutral.

Huntsville Hospital System Pharmacy Manager Jack Adams stated: "We're excited about using HCS Medication Reconciliation to improve medication reconciliation at our hospital. We plan to improve patient safety with the use of this solution."

Huntsville Hospital Project Manager Richa Airee stated: "The dedication of the HCS team is above and beyond anything I've ever experienced in implementation and support of a software solution. It is a pleasure to work with each of them."

For more information about why HCS Medication Reconciliation is THE market leader in medication reconciliation improvement, visit http://www.hcsinc.net or call sales 800-938-3844.


'/>"/>
SOURCE Health Care Systems, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Related medicine news :

1. PA-Based ACTS Retirement-Life Communities Announces Agreement to Acquire Carlton Cove in Huntsville, Alabama
2. Dr. Fay Raines From the University of Alabama in Huntsville Assumes Presidency of the American Association of Colleges of Nursing
3. Huntsville Pediatric Associates Selects DST Health Solutions Practice Management Solution for Billing, Accounts Receivable
4. Aethons Train-Themed Delivery Robot Available To Childrens Hospitals Nationwide
5. New research from Rhode Island Hospital may help predict outcomes for stomach cancer patients
6. Patient Satisfaction Higher at Most Wired Hospitals
7. AmeriCares Purchases 2nd BLU-MED Deployable Field Hospital for China Earthquake Relief
8. Florida Physicians Press Sen. Martinez to Support Reform of Medicare Bidding Program after Hospital Discharge Problems Emerge
9. Fragmented Los Angeles Hospital Market Provides Health Systems with Little Leverage to Negotiate Higher Reimbursement
10. Louisiana Department of Health and Hospitals Announces Intent to Award Cost Containment Services Contract to HMS
11. American Hospital Management Company Appoints Gregory Ciottone, MD as Chief Medical Officer
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/27/2016)... ... 27, 2016 , ... More than a third of American adults are considered ... surgery has received increased attention in recent years, as an article published ... weight loss, most people are familiar with the basic requirements of maintaining a healthy ...
(Date:5/27/2016)... ... ... With over 60 percent of acute stroke survivors being left unable to ... in the rehabilitation process has steadily increased. Ekso Bionics had been working to help ... stroke. , Ekso Bionics has now received clearance from the U.S. Food and Drug ...
(Date:5/27/2016)... ... May 27, 2016 , ... Aimed ... by inspiring human interest stories, courtesy of leaders in the nursing and health ... the industry, from leading advocates and associations—namely Jones & Bartlett Learning. , Jones ...
(Date:5/26/2016)... ... ... There are many ways to cook a hot dog, but new research commissioned ... dogs straight off the grill. Of the 90 percent of Americans who say they ... hot dog, far outpacing other cooking methods such as steaming (12 percent), microwaving (9 ...
(Date:5/26/2016)... , ... May 26, 2016 , ... Connor Sports, ... basketball as a partner for the Tamika Catchings Legacy Tour that will ... industry leader in hardwood basketball surfaces in all forms and levels of the game, ...
Breaking Medicine News(10 mins):
(Date:5/25/2016)... MedDay, a biotechnology company focused on the treatment ... "High doses of biotin in progressive multiple sclerosis: extension phase ... Ayman Tourbah , Principal Investigator of the Phase 3 ... Neurology (EAN) in Copenhagen, Denmark . The ... on Sunday, 29 May 2016 from 14:45 to 16:15 CEST ...
(Date:5/24/2016)... --   , ... Endpunkte und demonstriert Ebenbürtigkeit bei der Gesamtreinigung des ... guter , Reinigung des ... (Logo: http://photos.prnewswire.com/prnh/20130829/633895-a ) , ... der MORA-Studie der Phase III für NER1006 (1 ...
(Date:5/24/2016)... Celsion Corporation (NASDAQ: CLSN ... an update on its ongoing OVATION study, a ... the Company,s DNA-based immunotherapy, with the standard of ... advanced ovarian cancer who will undergo neoadjuvant chemotherapy ... IL-12 DNA plasmid vector formulated as a nanoparticle ...
Breaking Medicine Technology: